Healthcare
Live Price
Offline$355.44
-0.44% today
1Y Change
+4.13%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Waters Corporation (WAT) is a Healthcare stock with a market cap of $17.96B and listed on NYSE. The stock last traded around $355.44 and up 4.1% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +7.0%, EPS growth of +0.5%, a dividend yield of 0.0%. What stands out right now is revenue +7.0%, EPS +0.5%, free cash flow -12.9% with operating margin 26.6% and ROIC 14.1%. Valuation sits in the middle of the pack at P/E 28.0 and price/sales 5.7. Stock Foundry combines WAT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WAT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WAT Max Drawdown
-31.32%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WAT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.8B
-6.3% YoY
FY Net Income
$692.8M
-2.1% YoY
Free Cash Flow
$579.0M
+35.2% YoY
Revenue Growth
+7.0%
EPS Growth
+0.5%
Gross Margin
58.9%
Net Margin
20.3%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.2B | 3.0B | 3.0B | 3.0B | 2.8B |
| Gross Profit | 1.8B | 1.8B | 1.8B | 1.7B | 1.6B |
| Operating Income | 893M | 826M | 818M | 873M | 822M |
| EBITDA | 1.0B | 1.0B | 1.0B | 1.0B | 983M |
| Net Income | 643M | 638M | 642M | 708M | 693M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 588M | 324M | 395M | 481M | 501M |
| Total Assets | 5.1B | 4.6B | 4.6B | 3.3B | 3.1B |
| Total Liabilities | 2.5B | 2.7B | 3.5B | 2.8B | 2.7B |
| Shareholder Equity | 2.6B | 1.8B | 1.2B | 504M | 368M |
| Total Debt | 1.4B | 1.7B | 2.4B | 1.7B | 1.6B |
| Net Debt | 820M | 1.4B | 2.0B | 1.2B | 1.1B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
747M
+22.2% YoY
Capital Expenditures
168M
+8.3% YoY
Free Cash Flow
579M
+35.2% YoY
Key ratios
Gross Margin
58.9%
Operating Margin
26.6%
Net Margin
20.3%
ROE
28.5%
Debt / Equity
0.55x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.